- About TapImmune
- News & Media
- Contact Us
SEATTLE, May 20, 2015 /PRNewswire/ — TapImmune (TPIV), a clinic stage Cancer Immunotherapy Company, announced today that Dr. Glynn Wilson will present at the 2015 Marcum MicroCap Conference held Wednesday, May 27, 2015 and Thursday, May 28, 2015, at the Grand Hyatt New York. The...
SEATTLE, Wash., May 15, 2015 /PRNewswire/ – TapImmune, Inc. (TPIV), is pleased to announce that an Abstract on a Phase I Study on the Safety and Immunogenicity of a folate receptor alpha (FRAα) peptide vaccine has been published in J Clin. Oncol., 33:5s, 2015 (suppl; abstr e14028) which,...